Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency)
Top Cited Papers
Open Access
- 3 February 2011
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 117 (5), 1522-1529
- https://doi.org/10.1182/blood-2010-07-298372
Abstract
X-linked lymphoproliferative syndromes (XLP) are primary immunodeficiencies characterized by a particular vulnerability toward Epstein-Barr virus infection, frequently resulting in hemophagocytic lymphohistiocytosis (HLH). XLP type 1 (XLP-1) is caused by mutations in the gene SH2D1A (also named SAP), whereas mutations in the gene XIAP underlie XLP type 2 (XLP-2). Here, a comparison of the clinical phenotypes associated with XLP-1 and XLP-2 was performed in cohorts of 33 and 30 patients, respectively. HLH (XLP-1, 55%; XLP-2, 76%) and hypogammaglobulinemia (XLP-1, 67%; XLP-2, 33%) occurred in both groups. Epstein-Barr virus infection in XLP-1 and XLP-2 was the common trigger of HLH (XLP-1, 92%; XLP-2, 83%). Survival rates and mean ages at the first HLH episode did not differ for both groups, but HLH was more severe with lethal outcome in XLP-1 (XLP-1, 61%; XLP-2, 23%). Although only XLP-1 patients developed lymphomas (30%), XLP-2 patients (17%) had chronic hemorrhagic colitis as documented by histopathology. Recurrent splenomegaly often associated with cytopenia and fever was preferentially observed in XLP-2 (XLP-1, 7%; XLP-2, 87%) and probably represents minimal forms of HLH as documented by histopathology. This first phenotypic comparison of XLP subtypes should help to improve the diagnosis and the care of patients with XLP conditions.Keywords
This publication has 35 references indexed in Scilit:
- XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative diseaseBlood, 2010
- A novel XIAP mutation in a Japanese boy with recurrent pancytopenia and splenomegalyHaematologica, 2009
- Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiencyJCI Insight, 2009
- XIAP mediates NOD signaling via interaction with RIP2Proceedings of the National Academy of Sciences of the United States of America, 2009
- XIAP as a ubiquitin ligase in cellular signalingCell Death & Differentiation, 2009
- SAP-controlled T–B cell interactions underlie germinal centre formationNature, 2008
- LIMBIC ENCEPHALITIS AS PRESENTATION OF A SAP DEFICIENCYNeurology, 2007
- Regulation of Cellular and Humoral Immune Responses by the SLAM and SAP Families of MoleculesAnnual Review of Immunology, 2007
- Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the familyEMBO Reports, 2006
- Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative diseaseAmerican Journal of Medical Genetics, 1991